Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong
· Delayed Price · Currency is HKD 320.40
+7.40 (2.36%)
Mar 10, 2026, 11:59 AM HKT
Duality Biotherapeutics Market Cap
Duality Biotherapeutics has a market cap or net worth of 28.21 billion as of March 9, 2026.
Market Cap
28.21B
Enterprise Value
24.22B
Revenue
2.38B
Ranking
n/a
PE Ratio
n/a
Stock Price
320.40
Market Cap Chart
Since April 15, 2025, Duality Biotherapeutics's market cap has increased from 17.51B to 28.21B, an increase of 61.08%. That is a compound annual growth rate of 69.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 28.21B | 5.81% |
| Dec 31, 2025 | 26.66B | 52.24% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 32.13B |
| Genscript Biotech | 24.99B |
| InnoCare Pharma | 23.79B |
| PegBio | 23.50B |
| Biocytogen Pharmaceuticals (Beijing) | 35.60B |
| TransThera Sciences (Nanjing) | 36.71B |
| Shanghai Henlius Biotech | 37.50B |
| Zai Lab | 17.13B |